ABOUT
The Bosch Young Investigators (BYI) are a collective of postgraduate research students and junior postdoctoral researchers who undertake their research in one of the laboratories affiliated with the University of Sydney's School of Medicine.
​
The BYI are coordinated by a committee of young researchers, with each member representing a different discipline within the University of Sydney's School of Medicine. The Committee organises a number of events throughout the year with the primary purpose of each event to bring young researchers together. Given the sparse geographic spread of the laboratories and researchers, this is a fundamental aspect leading to the success of our program. These events are organised to encourage scientific exchange, promote awareness and encourage involvement of all young researchers, especially those new to the University of Sydney.
COMMITTEE
Gabi Gregoriou
Gabi is a PhD candidate in the Synaptic Physiology and Plasticity Laboratory. Her research focuses on how endogenously released opioid peptides regulate synaptic function and plasticity in the amygdala.
Sian Genoud
Sian is a PhD candidate in the Double Neurodegeneration Laboratory. Her project is based on investigating alterations in normal biometals and their associate proteins within degenerating regions of the Parkinson's disease brain and ALS spinal cord.
Sebastian Stefani
Sebastian is a PhD candidate in the Balance and Neurodegeneration (BaND) laboratory. His research is focused on the vestibular (balance) system of the central nervous system and how it regulates our sense of balance. His project looks at how the application of electrical noise/stimulation improves balance regulation.
Max Mo
Max is a PhD candidate in the Balance and Neurodegeneration (BaND) laboratory. His research is focused on neurodegenerative disorders such as Parkinsons Disease. Specifically, the electrical characteristics of neurons within key regions of the brain affected by Parkinsons Disease.
Leyla Fouani
Leyla is a PhD candidate in the Molecular Pharmacology and Pathology Program. Her research focus is on elucidating the molecular effects of the metastasis suppressor gene, NDRG1, in a variety of cancer types. She is also investigating whether she can exploit the advantageous anti-metastatic effects of NDRG1 through a new class of anti-cancer agents.
Tayler Wishart